Importantly, this data demonstrates that the blocking of E-selectin, and subsequent impact on the ability of leukemia cells to interchange between blood and marrow, alters the clearance rates of newly added donor CLCs as compared to an untreated diseased animal. The gene discussed is SELE; the disease is leukemia.